Literature DB >> 20418142

Socio-demographic and behavioral correlates of herpes simplex virus type 1 and 2 infections and co-infections among adults in the USA.

Hind A Beydoun1, Jessica Dail, Bethrand Ugwu, Adel Boueiz, May A Beydoun.   

Abstract

OBJECTIVES: Although herpes simplex virus (HSV)-1 and HSV-2 may co-exist and interact, some epidemiologic features including geographical distribution, secular trends, route of transmission, and established risk factors may distinguish these HSV sub-types. With recent data indicating a link between genital herpes and either strain, a re-evaluation of risk factors for HSV-1/HSV-2 infection and co-infection is needed.
METHODS: We used the 1999-2004 National Health and Nutrition Examination Study (NHANES) data and logistic regression modeling to identify socio-demographic and behavioral risk factors that can independently predict HSV-1/HSV-2 infection and co-infection.
RESULTS: Approximately 48% were positive for HSV-1 alone, 7% were positive for HSV-2 alone and 12% were co-infected with HSV-1 and HSV-2. History of genital herpes was found in individuals infected with either or both HSV sub-types. Whereas age, sex, race, and level of education independently predicted all three outcomes, lifetime sexual activity as well as use of tobacco products and recreational drugs mainly correlated with HSV-2 infection and HSV-1/HSV-2 co-infection. Lifetime use of alcohol was not consistently associated with HSV-1/HSV-2 infection and co-infection.
CONCLUSIONS: Sexual activity played an important role for HSV-2 and was potentially important for HSV-1, with implications for healthcare practice and vaccine development.
Copyright © 2010 International Society for Infectious Diseases. All rights reserved.

Entities:  

Keywords:  Epidemiology; Herpes simplex virus; Infection; Prevalence; Sexually transmitted diseases

Mesh:

Year:  2010        PMID: 20418142      PMCID: PMC2921001          DOI: 10.1016/j.ijid.2009.12.007

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  41 in total

1.  Prevalence and association between herpes simplex virus types 1 and 2-specific antibodies in attendees at a sexually transmitted disease clinic.

Authors:  R W Roest; W I van der Meijden; G van Dijk; J Groen; P G Mulder; G M Verjans; A D Osterhaus
Journal:  Int J Epidemiol       Date:  2001-06       Impact factor: 7.196

2.  A novel glycoprotein for detection of herpes simplex virus type 1-specific antibodies.

Authors:  F K Lee; L Pereira; C Griffin; E Reid; A Nahmias
Journal:  J Virol Methods       Date:  1986-09       Impact factor: 2.014

3.  Predictors of treatment receipt among adults with a drug use disorder.

Authors:  Joan F Epstein; Laurel L Hourani; David C Heller
Journal:  Am J Drug Alcohol Abuse       Date:  2004-11       Impact factor: 3.829

4.  The epidemiology of genital infection with herpes simplex virus types 1 and 2 in genitourinary medicine attendees in inner London.

Authors:  M Ramaswamy; C McDonald; C Sabin; M Tenant-Flowers; M Smith; A M Geretti
Journal:  Sex Transm Infect       Date:  2005-08       Impact factor: 3.519

5.  The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.

Authors:  J R Daling; M M Madeleine; B McKnight; J J Carter; G C Wipf; R Ashley; S M Schwartz; A M Beckmann; M E Hagensee; M T Mandelson; D A Galloway
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1996-07       Impact factor: 4.254

Review 6.  Epidemiology of herpes simplex virus type 2 infection in the developing world.

Authors:  Helen Weiss
Journal:  Herpes       Date:  2004-04

Review 7.  Epidemiology of genital herpes simplex virus infection in developed countries.

Authors:  Jean-Elie Malkin
Journal:  Herpes       Date:  2004-04

8.  Risk factors for infection with herpes simplex virus type 2: role of smoking, douching, uncircumcised males, and vaginal flora.

Authors:  Thomas L Cherpes; Leslie A Meyn; Marijane A Krohn; Sharon L Hillier
Journal:  Sex Transm Dis       Date:  2003-05       Impact factor: 2.830

9.  Prevalence and risk factors for herpes simplex virus type 2 infection among pregnant women in Israel.

Authors:  Michael Dan; Oscar Sadan; Marek Glezerman; David Raveh; Zmira Samra
Journal:  Sex Transm Dis       Date:  2003-11       Impact factor: 2.830

10.  The seroepidemiology of herpes simplex virus type 1 and 2 in Europe.

Authors:  R G Pebody; N Andrews; D Brown; R Gopal; H De Melker; G François; N Gatcheva; W Hellenbrand; S Jokinen; I Klavs; M Kojouharova; T Kortbeek; B Kriz; K Prosenc; K Roubalova; P Teocharov; W Thierfelder; M Valle; P Van Damme; R Vranckx
Journal:  Sex Transm Infect       Date:  2004-06       Impact factor: 3.519

View more
  11 in total

1.  Seroprevalence and correlates of herpes simplex virus type 2 infection among young adults in Arkhangelsk, Northwest Russia: a population-based cross-sectional study.

Authors:  Tatiana Balaeva; Andrej M Grjibovski; Oleg Sidorenkov; Olga Samodova; Natalia Firsova; Anatoly Sannikov; Elise Klouman
Journal:  BMC Infect Dis       Date:  2016-10-28       Impact factor: 3.090

2.  Associations between excessive adiposity and seroprevalence of herpes simplex virus type 1 and type 2 among US adults: a population-based age-period-cohort analysis.

Authors:  Su-Hsun Liu; I-Shiang Tzeng; Tsung-Han Hsieh; Yhu-Chering Huang
Journal:  BMJ Open       Date:  2016-10-17       Impact factor: 2.692

3.  Molecular analyses and phylogeny of the herpes simplex virus 2 US9 and glycoproteins gE/gI obtained from infected subjects during the Herpevac Trial for Women.

Authors:  Kelsey L Rowe; Miguel A Minaya; Robert B Belshe; Lynda A Morrison
Journal:  PLoS One       Date:  2019-03-08       Impact factor: 3.240

4.  Seroprevalence and associated factors of HSV-2 infection among general population in Shandong Province, China.

Authors:  Pengcheng Huai; Furong Li; Zhen Li; Lele Sun; Xi'an Fu; Qing Pan; Gongqi Yu; Zemin Chai; Tongsheng Chu; Zihao Mi; Fangfang Bao; Honglei Wang; Bingni Zhou; Chuan Wang; Yonghu Sun; Guiye Niu; Yuan Zhang; Fanghui Fu; Xiaoqiao Lang; Xiaoling Wang; Hui Zhao; Daina Liu; Hong Liu; Dianchang Liu; Jian Liu; Aiqiang Xu; Furen Zhang
Journal:  BMC Infect Dis       Date:  2019-05-06       Impact factor: 3.090

5.  Prevalence and correlates of Kaposi's sarcoma-associated herpesvirus and herpes simplex virus type 2 infections among adults: evidence from the NHANES III data.

Authors:  Xin Zhang; Yiyun Xu; Yi Li; Huangbo Yuan; Zhenqiu Liu; Tiejun Zhang
Journal:  Virol J       Date:  2022-01-06       Impact factor: 4.099

6.  Diet-induced obesity prolongs neuroinflammation and recruits CCR2(+) monocytes to the brain following herpes simplex virus (HSV)-1 latency in mice.

Authors:  Katherine A White; Scott R Hutton; Jill M Weimer; Patricia A Sheridan
Journal:  Brain Behav Immun       Date:  2016-06-13       Impact factor: 19.227

7.  Seroprevalence of Herpes Simplex Virus Type 1 and 2 in Taiwan and Risk Factor Analysis, 2007.

Authors:  Jen-Hsiang Shen; Kuan-Ying Arthur Huang; Chen Chao-Yu; Chih-Jung Chen; Tzou-Yien Lin; Yhu-Chering Huang
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

8.  Increased inflammatory response in cytomegalovirus seropositive patients with Alzheimer's disease.

Authors:  Gabriel Westman; David Berglund; Johan Widén; Martin Ingelsson; Olle Korsgren; Lars Lannfelt; Dag Sehlin; Anna-Karin Lidehall; Britt-Marie Eriksson
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

9.  SERO-prevalence of herpes simplex virus type 1 and type 2 among women attending routine Cervicare clinics in Ghana.

Authors:  Oksana Debrah; Francis Agyemang-Yeboah; Richard Harry Asmah; Emmanuel Timmy-Donkoh; Mohammed Mustapha Seini; Linda Ahenkorah Fondjo; Nilok Sight; Ellis Owusu-Dabo
Journal:  BMC Infect Dis       Date:  2018-08-07       Impact factor: 3.090

Review 10.  Herpes simplex virus 2 infection: molecular association with HIV and novel microbicides to prevent disease.

Authors:  Paula A Suazo; Eduardo I Tognarelli; Alexis M Kalergis; Pablo A González
Journal:  Med Microbiol Immunol       Date:  2014-09-11       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.